Literature DB >> 19728179

Loss of cytochrome P450 17A1 protein expression in a 17alpha-hydroxylase/17,20-lyase-deficient 46,XY female caused by two novel mutations in the CYP17A1 gene.

Nayelli Nájera1, Nayely Garibay, Yadira Pastrana, Icela Palma, Yolanda-Rocio Peña, Javier Pérez, Ninel Coyote, Alberto Hidalgo, Susana Kofman-Alfaro, Gloria Queipo.   

Abstract

17alpha-Hydroxylase deficiency (17OHD) is a rare form of congenital adrenal hyperplasia caused by mutations in the CYP17A1 gene. This condition shows considerable clinical and biochemical variation. Molecular characterization of novel mutations in the CYP17A1 gene and detailed study of their structural, enzymatic, and clinical consequences are required to fully understand enzyme behavior. Here, we present the first molecular characterization of two novel mutations in CYP17A1 in a 15-year-old female Mexican mestizo 46,XY female with primary amenorrhea and lack of pubertal development and severe hypertension that manifested only after surgery. A complete clinical and biochemical evaluation was compatible with 17OHD. Structural anomalies in the CYP17A1 gene were discovered by direct automated sequencing, which revealed a novel compound heterozygous K110X/R362H mutation that leads to a complete lack of enzyme activity. Immunohistochemical analyses performed to determine protein expression and localization showed that cytochrome P450 17A1 was completely absent in the patient's testicular tissue. Studies of novel mutations, such as those described here, provide important information that allows us to better understand the effect of a given mutation on enzyme function and to observe the impact of the mutation on clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728179     DOI: 10.1007/s12022-009-9088-9

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  24 in total

1.  Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency.

Authors:  Erica L T Van Den Akker; Jan W Koper; Annemie L M Boehmer; Axel P N Themmen; Miriam Verhoef-Post; Marianna A Timmerman; Barto J Otten; Stenvert L S Drop; Frank H De Jong
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency.

Authors:  Marivânia Costa-Santos; Claudio E Kater; Richard J Auchus
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

Review 3.  17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition.

Authors:  T Yanase; E R Simpson; M R Waterman
Journal:  Endocr Rev       Date:  1991-02       Impact factor: 19.871

4.  ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including Robinow syndrome.

Authors:  Ying Chen; William P Bellamy; Miguel C Seabra; Mark C Field; Bassam R Ali
Journal:  Hum Mol Genet       Date:  2005-07-27       Impact factor: 6.150

5.  A compound heterozygous mutation in the CYP17 (17alpha-hydroxylase/17,20-lyase) gene in a Chinese subject with congenital adrenal hyperplasia.

Authors:  Gin-Sing Won; Chih-Yang Chiu; Yi-Chu Tso; Shwu-Fen Jenq; Pi-Sung Cheng; Tjin-Shing Jap
Journal:  Metabolism       Date:  2007-04       Impact factor: 8.694

6.  Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene.

Authors:  Jun Yang; Bin Cui; Shouyue Sun; Tieliu Shi; Siyuan Zheng; Yufang Bi; Jianmin Liu; Yongju Zhao; Jialun Chen; Guang Ning; Xiaoying Li
Journal:  J Clin Endocrinol Metab       Date:  2006-06-13       Impact factor: 5.958

7.  Molecular modeling of human P450c17 (17alpha-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations.

Authors:  R J Auchus; W L Miller
Journal:  Mol Endocrinol       Date:  1999-07

8.  Genetic analysis of the cytochrome P-450c17alpha (CYP17) and aldosterone synthase (CYP11B2) in Japanese patients with 17alpha-hydroxylase deficiency.

Authors:  Y Takeda; T Yoneda; M Demura; K Furukawa; H Koshida; I Miyamori; H Mabuchi
Journal:  Clin Endocrinol (Oxf)       Date:  2001-06       Impact factor: 3.478

9.  Deletion of amino acids Asp487-Ser488-Phe489 in human cytochrome P450c17 causes severe 17 alpha-hydroxylase deficiency.

Authors:  C E Fardella; L H Zhang; P Mahachoklertwattana; D Lin; W L Miller
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

10.  Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency.

Authors:  M I New
Journal:  J Clin Invest       Date:  1970-10       Impact factor: 14.808

View more
  2 in total

1.  Clinical characteristics and mutation analysis of two Chinese children with 17a-hydroxylase/17,20-lyase deficiency.

Authors:  Ziyang Zhu; Shining Ni; Wei Gu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  A Rare Cause of Congenital Adrenal Hyperplasia: Clinical and Genetic Findings and Follow-up Characteristics of Six Patients with 17-Hydroxylase Deficiency Including Two Novel Mutations

Authors:  Aslı Derya Kardelen; Güven Toksoy; Firdevs Baş; Zehra Yavaş Abalı; Genco Gençay; Şükran Poyrazoğlu; Rüveyde Bundak; Umut Altunoğlu; Şahin Avcı; Adam Najaflı; Oya Uyguner; Birsen Karaman; Seher Başaran; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.